Morepen Laboratories

Morepen Laboratories EV/FCF

The EV/FCF (Enterprise Value to Free Cash Flow) of Morepen Laboratories (MOREPENLAB.NS) as of Oct 24, 2026 is -11.49. In the previous year, EV/FCF (Enterprise Value to Free Cash Flow) was -266.59 — a change of -95.69% (higher).

EV/FCF

-11.49

YoY

-95.69%

Last updated:

EV/FCF (Enterprise Value to Free Cash Flow) of Morepen Laboratories is 2025 -11.49 . EV/FCF (Enterprise Value to Free Cash Flow) of Morepen Laboratories was 2024 -266.59 . It decreases by -95.69% higher compared to the previous year.

The Morepen Laboratories EV/FCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/FCF
Date
EV/FCF
Jan 1, 2018
57.74 INR
Jan 1, 2019
382.01 INR
Jan 1, 2020
-348.94 INR
Jan 1, 2021
200.16 INR
Jan 1, 2022
-16.90 INR
Jan 1, 2023
-15.42 INR
Jan 1, 2024
-266.59 INR
Jan 1, 2025
-11.49 INR
The Morepen Laboratories EV/FCF history
YEAREV/FCFYoY
-11.49-95.69%
-266.59+1,628.78%
-15.42-8.73%
-16.90-108.44%
200.16-157.36%
-348.94-191.34%
382.01+561.60%
57.74-17.31%
69.83+25.82%
55.50+12.86%
49.17-37.33%
78.47—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Morepen Laboratories Stock analysis

What does Morepen Laboratories do? Morepen Laboratories Ltd. generates revenue through the manufacturing and marketing of bulk drugs, pharmaceutical formulations, and home health products. The company produces active pharmaceutical ingredients (APIs) such as Apixaban, Edoxaban, Sitagliptin, and Rivaroxaban, which are sold to other pharmaceutical manufacturers. Its finished formulations, including Intebact Capsules, Intelicaps Lax, and Rythmix Kid Syrup, are marketed under its own brand for direct consumer sales. Home health products like the Dr. Morepen 49W Room Air Purifier and Dr. Morepen VP06 Breathe Free Vaporizer are sold directly to consumers through retail channels. The company's subsidiaries, Dr. Morepen Limited, Morepen Devices Limited, and Total Care Limited, support these product lines by handling specific manufacturing and distribution tasks. The primary customers for APIs are pharmaceutical companies seeking bulk ingredients for their own formulations. Finished formulations target healthcare consumers and pharmacies, while home health products are sold to households and medical facilities. The company's product segments are clearly divided: APIs for industrial clients, branded formulations for retail consumers, and home health devices for personal use. This segmentation allows Morepen to serve multiple market segments without overlapping product lines. Morepen's revenue streams are diversified across three main areas: API sales to pharmaceutical manufacturers, direct-to-consumer sales of branded formulations, and retail sales of home health products. The company's subsidiaries play a key role in supporting each segment, with Dr. Morepen Limited handling branded formulations, Morepen Devices Limited managing home health devices, and Total Care Limited likely supporting broader healthcare services. This structure ensures that each product line is efficiently managed and marketed to its respective target audience. Morepen Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Morepen Laboratories stock

EV/FCF (Enterprise Value to Free Cash Flow) of Morepen Laboratories is -11.49 in 2025.

EV/FCF (Enterprise Value to Free Cash Flow) of Morepen Laboratories changed from -266.59 to -11.49, representing a -95.69% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/FCF (Enterprise Value to Free Cash Flow) Morepen Laboratories since 2006 – with annual values, charts, and detailed analysis.

The EV/FCF ratio measures the enterprise value relative to free cash flow. It captures the true cash-generating ability of a business.

To evaluate EV/FCF (Enterprise Value to Free Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/FCF (Enterprise Value to Free Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/FCF (Enterprise Value to Free Cash Flow)'s Morepen Laboratories with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Morepen Laboratories

All Key Metrics — Morepen Laboratories